Lakewood-amedex Biotherapeutics (LABT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Lakewood-Amedex Biotherapeutics Inc.  (Nasdaq: LABT)

Lakewood-amedex Biotherapeutics Profitability Comparisons

Select each Category to receive further Information




LABT Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 68.81 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) - 68.6 % 55.57 % 38.1 %
Gross Profit Margin 5 Yr. Avg. - 54.59 % 50.06 % 26.65 %
EBITDA Margin (Q2 MRQ) - 22.25 % 19.62 % 20.72 %
EBITDA Margin (Q2 TTM) - 25.28 % 21.02 % 19.28 %
EBITDA Margin 5 Yr. Avg. - 22.39 % 18.01 % 11.14 %
Operating Margin (Q2 MRQ) - 17.3 % 16.59 % 16.03 %
Operating Margin (Q2 TTM) - 20.31 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. - 18.61 % 12.01 % 8.21 %
Pre-Tax Profit Margin (Q2 MRQ) - 13.66 % 10.94 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) - 16.68 % 12.84 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 21.15 % 12.23 % 8.29 %
Net Margin (Q2 MRQ) - 10.08 % 8.14 % 11.41 %
Net Margin (Q2 TTM) - 13.13 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 15.99 % 7.98 % 6.33 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) - 14.7 % 13.26 % 9.53 %
Free Cash Flow Margin (Q2 TTM) - 17.25 % 14.06 % 9.26 %
Free Cash Flow Margin 5 Yr. Avg. - 22.22 % 13.86 % 9.05 %
Net Cash Flow Margin (Q2 MRQ) - -1.43 % 1.7 % 2.36 %
Net Cash Flow Margin (Q2 TTM) - -0.76 % 0.09 % 1.8 %
Net Cash Flow Margin 5 Yr. Avg. - 0.26 % 1.42 % 1.41 %
Effective Tax Rate (Q2 MRQ) - 25.97 % 25.4 % 18.84 %
Effective Tax Rate (Q2 TTM)